DSIP for trensomnia at 200mcg per night, mechanistic question and data request

Running 175mg Tren Ace per week alongside Test P at 700mg. Sleep disruption started at week 3 - waking at 3am, elevated resting heart rate, classic Tren CNS overstimulation. Added DSIP at 100mcg per day, increased to 200mcg at week 2. Results are observable but I want better data before drawing conclusions. DSIP is not a sedative - it modulates GABAergic and serotonergic pathways and normalises circadian function through accumulation, not immediate sedation. Effect builds over weeks. Who else has tracked this properly? At what dose and week did you see consistent improvement, and are you combining it with anything else?

DSIP mechanism is the part most people miss. You are right that it is not a sedative. The people who dose it once and say it does not work are expecting a knock-out pill. It modulates circadian rhythm over weeks. My experience running it at 200mcg - noticeable improvement by week 3, consistent by week 5. Combined with propranolol at bedtime to handle the Tren-driven heart rate spike. The two-compound approach is where the real fix comes from. DSIP alone on heavy Tren is partial. Add the beta blocker.

The mechanism distinction is exactly right. DSIP does not sedate - it normalises circadian function through GABAergic and serotonergic pathway modulation. The effect is cumulative and requires weeks to establish. I have run it at 200mcg per day on two separate Tren cycles. First time I dosed it for 5 days, noticed nothing, stopped. Second time I understood the mechanism and ran it for 6 weeks. The difference was real and measurable by week 3. The combination with beta blockers for the cardiovascular component of trensomnia is what produces consistent results.

The GABAergic pathway modulation and serotonergic normalisation that DSIP operates through requires sustained plasma levels to produce measurable circadian entrainment. A 3-4 day trial at any dose tells you nothing about the compound. The correct interpretation of a failed DSIP trial is almost always insufficient duration rather than ineffectiveness of the compound. Six weeks minimum at 150-200mcg with bloods confirming product quality is the assessment protocol. Propranolol for the cardiovascular CNS component alongside DSIP for the circadian component is the complete trensomnia stack.